8. Lipopoloysaccharides and other bacterial
components activate neutrophils and vascular
endothelium
Cytokines and complement activation lead to
vascular instability
Increase in tissue factor leads to microvascular
occlusion
Combination leads to coagulopathy,
vasodilation and capillary leak
9. Early antibiotic therapy (within 1 hour of
presentation) decreases mortality
Check hospital antibiogram
Target the most likely source
Start broad, narrow later
When all else fails:
Cefepime 1 gm IV and Vancomycin 15mg/kg
Note: generally, anaerobes are NOT a cause of sepsis
except in rare intraabdominal cases
10. Algorithmic approach to management of
severe sepsis
Inclusion: 2/4 SIRS, SBP ≤90 after fluids or serum
lactate >4
Then randomly assigned to standard therapy or EGDT
With their EGDT protocol:
Reduction in sudden cardiovascular collapse
Mortality reduction:
Standard therapy in-hospital mortality: 46.5%
EGDT in-hospital mortality: 30.5% 16% Absolute
reduction in
mortality
11. Patients with severe sepsis with signs of
hypoperfusion/end-organ dysfunction
Lactate > 4 mmol/L
(The patient does NOT need to be hypotensive)
Patients with septic shock
12. Goal-directed hemodynamic resuscitation of
severe sepsis / septic shock:
Optimize CO: preload, afterload, and contractility
Restore systemic oxygen content
Oxygen Delivery (DO2) = CO x CaO2
DO2 = CO x (1.34 * Hb * SaO2) + (0.003 * PaO2)
Preserve tissue perfusion
Avoid increases in myocardial O2 consumption
13. CVP of 8 – 12 mm Hg
Controversy about using CVP as no direct correlation to
volume responsiveness
MAP of >65 mm Hg
UOP ≥ 0.5 ml/kg/h
Normalization of Lactate
ScvO2 ≥ 70%
ScvO2 = from CVP
SvO2 = from PA catheter
14. 20-40ml/kg bolus
Looking for recruitable CO
Increase in BP with fluid challenge
Pressors only after adequate fluid challenge
16. Vasopressors to MAP of > 65
Once initial fluid resuscitation
has been completed*
Arterial line placement is needed
at some point
Pressors of choice
Norepi +/- Vasopressin
Epi
If patient does not respond to
fluids and pressors,
Hydrocortisone should be given
18. Achieve ScvO2 ≥ 70%
Initial fluid resuscitation
Blood transfusions to HCT >
30%**
1 U PRBC will raise HCT ~ 3% or
Hgb 1 gram
Inotropic therapy
Decrease O2 consumption
Major users are muscles of
respiration
Intubation, sedation, and paralysis
may be needed
19. Dobutamine
Use when ScvO2 < 70% despite fluids and HCT >
30%
Improves contractility
Use in combination with vasopressor because of
vasodilatory effect
Dose: 2.5 to 20 mcg/kg/min
Major adverse effect: dysrhythmias
20. Central Access in order to follow ScvO2
Arterial Line: especially if patient requires
pressors
Intubation if patient hypoxemic or with
significant altered mental status
Early intubation can decrease oxygen consumption
by decreasing work of breathing
21. Within 3 hours:
Get lactate level
Blood cx
Abx (within 1hour)
Fluid resuscitation
22. Early recognition of sepsis is key in lowering
mortality
Early antibiotics
Early Goal Directed Therapy in appropriate
patients
Appropriate access
Being Aggressive
Editor's Notes
SIRS is a sign of inflammation, not infection
EGDT added TLC with measurement and management of SvO2
In hospital as well as 28 and 60 day mortality was reduced
*hypovolemia still may not be resolved but may require pressors after initial fluid challenge
HCT 30 goal only for first 6 hours of resus then goal transfusion goal <7 unless patient with ongoing ischemia, hemorrhage or severe hypoxemia and resolution of tissue hypoperfusion
SvO2 - True mixed venous oxygen saturation from PA catheter, ScvO2 - Central venous oxygen saturation from TLC
Target >65% for SvO2 (5% difference due to the mixing of venous blood from the atrial and coronary sinus blood)